Showing 4581-4590 of 5805 results for "".
- Novartis: New Data Show Cosentyx Has Durable Response Across Psoriatic Diseasehttps://practicaldermatology.com/news/novartis-new-data-show-cosentyx-has-durable-response-across-psoriatic-disease/2460068/A new comprehensive analysis shows the long-term efficacy and safety of secukinumab in multiple manifestations of psoriatic disease, including moderate-to-severe plaque-type, nail and palmoplantar psoriasis, psoriatic arthritis and ankylosing spondylitis. Data are derived from key Phase 3, random
- Lilly: 5-Year Sustained Efficacy and Safety Results for Taltz in Plaque Psoriasis at WCDhttps://practicaldermatology.com/news/lilly-5-year-sustained-efficacy-and-safety-results-for-taltz-in-plaque-psoriasis-at-wcd/2460066/Patients with moderate- to severe plaque psoriasis who continued to receive Taltz® (ixekizumab) maintained high levels of skin clearance with no unexpected safety outcomes for up to five years of treatment, according to new data Eli Lilly and Company is presenting at the World Congress of Der
- Gillette Skin Guard Reduces Razor Bumps by 60%https://practicaldermatology.com/news/gillette-skin-guard-reduces-razor-bumps-by-60/2460065/Gillette’s recently launched SkinGuard razor is helping men who are susceptible to razor bumps, also known as Pseudofolliculitis barbae or PFB, new research shows. Results from a recent clinical study from Wake Forest University revealed that the incidence of men’
- Data Show 2-Year Complete Response with AbbVie's Skyrizi: WCDhttps://practicaldermatology.com/news/data-show-2-year-complete-response-with-abbvies-skyrizi-wcd/2460064/New results presented by AbbVie show that a significant number of patients treated with Skyrizi™ (risankizumab) experienced complete skin clearance at week 94. These two-year results (up to 104 weeks) from the Phase 3 IMMhance study, evaluating the efficacy and safety of SKYRIZI in adu
- Skin Metabolomics: Estee Lauder Presents New Research at WCDhttps://practicaldermatology.com/news/skin-metabolomics-estee-lauder-presents-new-research-at-wcd/2460063/The Estée Lauder Companies Inc.Research & Development (R&D) team will present data focused on new findings in skin metabolomics, skin defense, ingredient science, and anti-aging research at the 2019 World Congress of Dermatology (WCD) in Milan, Italy from June 10 -15.
- Burt's Bees Data at WCD Highlights Power of Naturalshttps://practicaldermatology.com/news/burts-bees-data-at-wcd-highlights-power-of-naturals/2460062/New research from Burt's Bees supports findings related to the skin's composition and the role of nature-based regimens to protect the skin against common environmental stressors. The studies will be presented at the 24th World Congress of Dermatology (WCD) Meeting in Milan
- Registration Open for Skin of Color Update Meetinghttps://practicaldermatology.com/news/registration-open-for-skin-of-color-update-meeting/2460060/The medical education event focused on the dermatologic treatment of skin of color has a new name. Skin of Color Update, previously the Skin of Color Seminar Series, provides dermatologists with evidence-based research and practical pearls in treating skin of color, including patients with multir
- Advanced Dermatology and Cosmetic Surgery Acquires Advanced Dermatology of Southern Marylandhttps://practicaldermatology.com/news/advanced-dermatology-and-cosmetic-surgeryacquires-advanced-dermatology-of-southern-maryland/2460057/Advanced Dermatology and Cosmetic Surgery (ADCS) has acquired the dermatology practice of Dr. Robyn James with locations in Fort Washington and La Plata, MD. Advanced Dermatology of Southern Maryland (ADSM), will continue to be led by Dr. James and Dr. Jeffrey Weddington, dermatologists who have
- Water's Edge Dermatology Acquires Coast Dermatologyhttps://practicaldermatology.com/news/waters-edge-dermatology-acquires-coast-dermatology/2460055/Water's Edge Dermatology, a provider of comprehensive dermatology services through 37 Florida locations, has acquired a controlling interest in Coast Dermatology, a medical/cosmetic dermatology practice in Venice, Florida. Terms of the transaction were not disclosed. This transactio
- Revance Therapeutics Welcomes Jill Beraud to Board of Directorshttps://practicaldermatology.com/news/revance-therapeutics-welcomes-jill-beraud-to-board-of-directors/2460053/Jill Beraud is now a member of Revance Therapeutics, Inc.'s Board of Directors. Ms. Beraud brings more than 25 years’ experience building luxury, fashion, beauty, and consumer brands. Ms. Beraud will also chair a newly-formed Revance Brand